PBLS · Parabilis Medicines, Inc. · Held by Funds
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of PBLS by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 1.99% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.03% | 35,962 |
| Index ETFs | 1.96% | 2,424,217 |
| Active ETFs | 0.00% | 0 |
| Active funds | 1.76% | 2,168,765 |
| Unclassified | 0.00% | 0 |
| All registered funds | 3.75% | 4,628,944 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding PBLS
41 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,121,000 | $30,681,770 | 0.00% | Long | 2026-06-30 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 807,764 | $22,108,501 | 0.01% | Long | 2026-06-30 | |
| Fidelity Growth Company Fund | — | 478,759 | $18,676,389 | 0.02% | Long | 2026-08-31 | |
| Select Biotechnology Portfolio | FBIOX | 436,412 | $17,024,432 | 0.27% | Long | 2026-08-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 486,669 | $13,320,131 | 0.11% | Long | 2026-06-30 | |
| JPMorgan Small Cap Growth Fund | — | 480,209 | $13,143,320 | 0.50% | Long | 2026-06-30 | |
| MFS New Discovery Fund | — | 271,771 | $10,601,787 | 0.49% | Long | 2026-08-31 | |
| AB Small Cap Growth Portfolio | — | 329,809 | $9,026,872 | 0.29% | Long | 2026-06-30 | |
| Janus Henderson Global Life Sciences Fund | — | 313,255 | $8,573,789 | 0.15% | Long | 2026-06-30 | |
| VANGUARD SMALL-CAP VALUE INDEX FUND | — | 255,694 | $6,998,345 | 0.01% | Long | 2026-06-30 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 239,759 | $6,562,204 | 0.01% | Long | 2026-06-30 | |
| Franklin Small Cap Growth Fund | — | 156,411 | $5,314,846 | 0.22% | Long | 2026-07-31 | |
| Fidelity Growth Company K6 Fund | FGKFX | 134,441 | $5,244,543 | 0.02% | Long | 2026-08-31 | |
| Federated Hermes Kaufmann Fund | — | 151,500 | $5,147,970 | 0.10% | Long | 2026-07-31 | |
| JPMorgan Small Cap Blend Fund | — | 154,583 | $4,230,937 | 0.25% | Long | 2026-06-30 | |
| Small Cap Core Portfolio | — | 128,992 | $3,530,511 | 0.41% | Long | 2026-06-30 | |
| Fidelity Series Growth Company Fund | FCGSX | 90,500 | $3,530,405 | 0.01% | Long | 2026-08-31 | |
| SmallCap Growth Fund I | — | 100,169 | $3,403,743 | 0.14% | Long | 2026-07-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 119,911 | $3,281,964 | 0.02% | Long | 2026-06-30 | |
| Franklin Biotechnology Discovery Fund | — | 93,010 | $3,160,480 | 0.27% | Long | 2026-07-31 | |
| Federated Hermes Kaufmann Small Cap Fund | — | 91,500 | $3,109,170 | 0.11% | Long | 2026-07-31 | |
| Fidelity Blue Chip Growth Fund | — | 89,581 | $3,043,962 | 0.00% | Long | 2026-07-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 71,285 | $2,780,828 | 0.01% | Long | 2026-08-31 | |
| Multi-Manager Small Cap Equity Strategies Fund | CZMSX | 63,637 | $2,482,479 | 0.22% | Long | 2026-08-31 | |
| Fidelity Blue Chip Growth ETF | FBCG | 66,150 | $2,247,777 | 0.03% | Long | 2026-07-31 | |
| MFS New Discovery Series | — | 79,479 | $2,175,340 | 0.27% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index ETF | ONEQ | 28,044 | $1,093,996 | 0.01% | Long | 2026-08-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 30,358 | $830,898 | 0.11% | Long | 2026-06-30 | |
| Fidelity Blue Chip Growth K6 Fund | FBCGX | 18,609 | $632,334 | 0.00% | Long | 2026-07-31 | |
| VANGUARD BALANCED INDEX FUND | — | 19,082 | $522,274 | 0.00% | Long | 2026-06-30 | |
| Fidelity Series Blue Chip Growth Fund | FSBDX | 15,089 | $512,724 | 0.00% | Long | 2026-07-31 | |
| AVIP AB Small Cap Portfolio | — | 17,417 | $476,703 | 0.15% | Long | 2026-06-30 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 16,880 | $462,006 | 0.00% | Long | 2026-06-30 | |
| Health Sciences Trust | — | 10,131 | $277,285 | 0.11% | Long | 2026-06-30 | |
| Tema Healthcare AI ETF | HLTH | 6,543 | $255,242 | 3.33% | Long | 2026-08-31 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 7,141 | $195,449 | 0.11% | Long | 2026-06-30 | |
| AB Small Cap Growth Portfolio | — | 6,296 | $172,322 | 0.30% | Long | 2026-06-30 | |
| Federated Hermes Kaufmann Fund II | — | 3,200 | $87,584 | 0.08% | Long | 2026-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 1,315 | $35,992 | 0.00% | Long | 2026-06-30 | |
| MFS Global Alternative Strategy Fund | — | 769 | $26,131 | 0.01% | Long | 2026-07-31 | |
| Fidelity Small Cap Growth K6 Fund | FOCSX | 1 | $34 | 0.00% | Long | 2026-07-31 |